The analyzed variables provide information about the dosage, vaccine application and adherence to the complete basic scheme (CBS). During the study period, two vaccination schemes were identified excluding booster doses [4]. Summarizing, there were 22 dependent variables (DV), which corresponded to the eight doses from the first scheme, 12 from the second, and two dose-indicators (one for each CBS).

The first scheme is valid during the 2000 and 2006 surveys, including Bacillus Calmette and Guerin (BCG), pentavalent, Sabin and vaccine against measles, mumps, and rubella (MMR). The second scheme, valid for the 2010, 2012 and 2018 surveys, includes BCG, pentavalent acellular, against hepatitis B, pneumococcus, rotavirus, and MMR [4]. Table 1 shows the recommended application age for each dose. Considering that most of these doses are applied during the first 11 months of life, four age groups were defined for children under one-year-old and other groups were defined for children of one, two, three, and four years old. Therefore, the corresponding doses estimated coverage is presented for each of these age groups.

BCG, Bacillus Calmette-Guerin vaccine; PV, complete cells pentavalent vaccine; PVa, acellular pentavalent vaccine; HB, Vaccine against Hepatitis B; Pnm, Conjugate vaccine against Pneumococcal; RV, Vaccine against rotavirus; MMR, Vaccine against measles, mumps, and rubella.

a Vaccination scheme valid during the 2000 and 2006 surveys.

b Vaccination scheme valid during the 2010, 2012 and 2018. The boost doses were not included (3 Pnm, 3 RV y 4 Pva).

The variables indicating adherence to the basic scheme, meaning they have the indicated doses or missing at least one of the doses. They are reported at the state level and for two age groups: 6 to 11 months, where seven out of eight doses (first scheme), and 11 out of 12 doses (second scheme) must be applied; and 12 to 23 months, where all children should have received all their doses.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.